Are you ready to change the field of epilepsy research?
** Now Accepting Applications for the CURE Epilepsy Education Enrichment Fund Scholarship
------------------------------------------------------------
Are you ready to change the field of epilepsy research? You could receive up to $5,000 toward your education through the CURE Epilepsy Education Enrichment Fund Scholarship ([link removed]) , funded by the generous support of Greenwich Biosciences. We're accepting applications now through April 15, 2021.
These one-time scholarships are awarded to individuals with epilepsy or family members and caregivers of those impacted by epilepsy. These scholarships support coursework in scholars’ chosen fields, so they can use their knowledge and skills to become agents of change in the epilepsy community.
Know someone eager to make a difference in the epilepsy community? Forward this email to them so they can apply for an Education Enrichment Fund Scholarship today!
[link removed] [link removed]
Our mission is to find a cure for epilepsy, by promoting and funding patient-focused research. CURE Epilepsy is a non-profit 501(c)(3) tax-exempt organization. Our tax identification number is 36-4253176.
[link removed]
[link removed]
[link removed]
[link removed]
[link removed]
[link removed]
============================================================
Copyright © 2020 CURE Epilepsy, All rights reserved.
In the past you provided CURE Epilepsy your email address. Occasionally, you will receive updates from us about epilepsy research and news.
Our mailing address is:
CURE Epilepsy
420 Wabash Ave, Ste 650
Chicago, IL 60611
USA
Want to change how you receive these emails?
You can ** update your preferences ([link removed])
or ** unsubscribe from this list ([link removed])
.
This email was sent to
[email protected] (mailto:
[email protected])
why did I get this? ([link removed]) unsubscribe from this list ([link removed]) update subscription preferences ([link removed])
CURE Epilepsy . 420 Wabash Ave, Ste 650 . Chicago, IL 60611 . USA
